Mounjaro TIRZEPATIDE injection

Mounjaro, containing the active ingredient Tirzepatide, is a prescription medication used for the treatment of type 2 diabetes and chronic weight management. It was developed and is manufactured by Eli Lilly and Company, a major American pharmaceutical corporation.

The drug's manufacturing process is complex, involving high-tech facilities primarily located in the United States, particularly in North Carolina and Indiana. However, due to global demand, Eli Lilly operates a robust global supply chain with significant manufacturing operations and expansion projects in Ireland (Limerick) and Germany (Alzey).

Since its founding in the late 19th century, Eli Lilly has remained an independent entity and is currently one of the largest pharmaceutical companies in the world by market capitalization. The brand is managed directly by the corporate headquarters in Indianapolis, with various local subsidiaries handling distribution and clinical studies globally.